Clinical Trials Browser

Phase 2 × Diarrhea × 1 year × Clear all

Diarrhea, Multiple Myeloma

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

Clinical Trials

A Study of Colesevelam for Lenalidomide-Associated Diarrhea

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis